Breiter Capital Management Inc. cut its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 4.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,385 shares of the healthcare conglomerate’s stock after selling 111 shares during the period. Breiter Capital Management Inc.’s holdings in UnitedHealth Group were worth $701,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. Selective Wealth Management Inc. acquired a new stake in UnitedHealth Group in the third quarter valued at approximately $27,000. North Star Investment Management Corp. acquired a new stake in UnitedHealth Group in the third quarter valued at approximately $30,000. Delta Asset Management LLC TN boosted its stake in UnitedHealth Group by 111.0% in the third quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 81 shares in the last quarter. Fusion Family Wealth LLC boosted its stake in UnitedHealth Group by 329.7% in the third quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 122 shares in the last quarter. Finally, Massey Quick Simon & CO. LLC boosted its stake in UnitedHealth Group by 212.5% in the third quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock valued at $38,000 after acquiring an additional 119 shares in the last quarter. Hedge funds and other institutional investors own 85.79% of the company’s stock.
A number of research firms have issued reports on UNH. Jefferies Financial Group cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and decreased their price target for the stock from $300.00 to $235.00 in a report on Thursday, October 10th. Morgan Stanley reaffirmed a “buy” rating and issued a $312.00 price target (up previously from $294.00) on shares of UnitedHealth Group in a report on Friday, November 22nd. Raymond James raised their price target on shares of UnitedHealth Group from $300.00 to $320.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. UBS Group raised their price target on shares of UnitedHealth Group from $279.00 to $304.00 and gave the stock a “neutral” rating in a report on Thursday, January 16th. Finally, Credit Suisse Group raised their price target on shares of UnitedHealth Group from $320.00 to $330.00 and gave the stock an “outperform” rating in a report on Wednesday, January 8th. Five analysts have rated the stock with a hold rating and nineteen have issued a buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and an average price target of $313.50.
In related news, CAO Thomas E. Roos sold 1,177 shares of the business’s stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $255.04, for a total transaction of $300,182.08. Following the transaction, the chief accounting officer now directly owns 21,687 shares in the company, valued at $5,531,052.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP D Ellen Wilson sold 7,400 shares of the business’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $272.77, for a total transaction of $2,018,498.00. In the last quarter, insiders sold 23,577 shares of company stock worth $6,810,430. Company insiders own 0.87% of the company’s stock.
Shares of NYSE UNH opened at $299.46 on Friday. The company’s 50-day simple moving average is $291.61 and its 200-day simple moving average is $257.23. UnitedHealth Group Inc has a 52-week low of $208.07 and a 52-week high of $302.54. The firm has a market cap of $284.73 billion, a price-to-earnings ratio of 20.90, a price-to-earnings-growth ratio of 1.47 and a beta of 0.65. The company has a quick ratio of 0.70, a current ratio of 0.69 and a debt-to-equity ratio of 0.61.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.77 by $0.13. UnitedHealth Group had a net margin of 5.71% and a return on equity of 25.55%. The business had revenue of $60.90 billion for the quarter, compared to analyst estimates of $61.17 billion. During the same quarter last year, the business earned $3.28 earnings per share. The company’s revenue for the quarter was up 4.3% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Inc will post 16.47 EPS for the current fiscal year.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: Sell-Side Analysts
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.